Metharose Sugar Free (Methadone Hydrochloride Ph. Eur.)

Methadone acts as a full agonist at the mu‑opioid receptors in the central nervous system. By binding to these receptors, it blocks pain signals and reduces the neurochemical drive that causes opioid cravings and withdrawal, providing both analgesic and maintenance effects.

The appropriate dose of Metharose Sugar Free is determined individually by a qualified prescriber based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Dosage adjustments are made under medical supervision.

Methadone is classified as Pregnancy Category C, indicating that potential benefits may justify use despite possible risks. It can cross the placenta and be present in breast milk; therefore, treatment decisions should involve a healthcare professional weighing maternal benefits against fetal or infant exposure.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Methadone has a long half‑life and provides stable plasma levels, which can reduce dosing frequency compared with shorter‑acting opioids like morphine. Its oral formulation allows convenient administration, but it requires careful cardiac monitoring due to QT prolongation risk, a consideration less prominent with some alternatives.

Store Metharose Sugar Free at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Metharose Sugar Free is taken orally, usually as a tablet or oral solution, as directed by the prescribing clinician. The dose is swallowed with water and should be taken at the same times each day to maintain consistent blood levels.

The most serious risks include respiratory depression, especially when combined with other CNS depressants, and cardiac arrhythmias due to QT interval prolongation. Patients should be monitored for signs of severe sedation, breathing difficulties, or irregular heart rhythms.

Metharose Sugar Free is contraindicated in individuals with known hypersensitivity to methadone, severe respiratory insufficiency, or uncontrolled cardiac arrhythmias. It should also be used with caution in patients with significant liver impairment or those taking interacting medications.